← Eichor
Study identifier: NCT06428032 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Functional and Neuroplastic Effects of HABIT-ILE in Children With Bilateral Cerebral Palsy

Condition: Cerebral Palsy  ·  Sponsor: Universidad Nacional Andres Bello

PhaseNA
Planned participants48
Who can joinAll sexes, 8 Years to 18 Years
Healthy volunteersNo

About this study

This randomized controlled trial will compare the effects of neuroplastic and functional changes of Hand-Arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE) when presented in two periods (2HG; n=24) versus a single period (1HG; n=24) in people with bilateral CP. The 1HG will receive 65 hours of HABIT-ILE over one intervention period; the 2HG will receive 130 hours over two intervention periods, within 6 months apart. Children will be assessed at 6 time points: baseline, three weeks after the start, at 3, 6, 7 and 9 months after the start of the study.

This description comes directly from the study's public registry record.

Talk to the study team

Rodrigo Araneda, PhD  ·  +56 22 6618608  ·  rodrigo.araneda@unab.cl

Natalia Perez, MSc  ·  +56 22 6618075  ·  n.perezramirez2@uandresbello.cl

Always discuss trial participation with your own doctor first.

Locations (1)

Exercise and Rehabilitation Sciences Institute, Universidad Nacional Andres BelloSantiago, Santiago Metropolitan, ChileRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06428032